What does Avidity Partners Management LP hold? Q1 2026 13F Holdings & Portfolio

AI Analysis · Q1 2026 · Q1 2026

Avidity Partners Management LP filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight

DIANTHUS THERAPEUTICS INC

$361M4.2M38.6%

ORUKA THERAPEUTICS INC

$89M1.5M9.5%

CG ONCOLOGY INC

$87M1.3M9.3%

JADE BIOSCIENCES INC

$54M2.8M5.8%

PERSPECTIVE THERAPEUTICS INC

$49M12.1M5.2%

ENLIVEN THERAPEUTICS INC

$32M800K3.4%

CONTEXT THERAPEUTICS INC

$25M10.0M2.7%

TEVA PHARMACEUTICAL INDS LTD

$21M650K2.2%

REPLIGEN CORP

$18M156K2.0%

PALVELLA THERAPEUTICS INC NE

$18M140K1.9%

Filing history loading…